Zhuoling Zheng – InmunoES

Discovery of plasma metabolomic biomarkers and a predictive model for immune checkpoint inhibitor-associated myocarditis: a pilot case-control study

15 de September de 2026 by Zhuoling Zheng

BackgroundImmune checkpoint inhibitor (ICI)-associated myocarditis is a rare but potentially fatal immune-related adverse event lacking reliable biomarkers for risk stratification. This exploratory pilot case-control study aimed to characterize baselin…

Integrated risk stratification for ICI-associated myocarditis: a baseline hematological profile and a combined ECG and enzymatic signature at onset

31 de March de 2026 by Zhuoling Zheng

BackgroundImmune checkpoint inhibitor-associated myocarditis (ICI-associated myocarditis) is a rare but fatal immune-related adverse event. Early identification of high-risk patients remains challenging. This study aimed to identify risk factors and de…